Treatment failure (escalation of respiratory therapy to NIV, NIPPV or invasive ventilation) Measured up to 28 days · adults in the ICU, requiring respiratory support
HFNC may leads to lower treatment failure (escalation of respiratory therapy to NIV, NIPPV… compared with standard oxygen therapy (low certainty).
1 finding from 1 review
Respiratory effects: PaO2/FiO2 ratio up to 24 hours after initiation of therapy · adults in the ICU, requiring respiratory support
1 finding from 1 review
Use of conventional phototherapy, if sunlight (with or without filters or amplification) was first used for prevention or early treatmentc · infants with confirmed hyperbilirubinemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hyperthermia while receiving sunlight or conventional phototherapyg · infants with confirmed hyperbilirubinemia
Sunlight (with or without filters or amplification) probably leads to higher hyperthermia while receiving sunlight or conventional phototherapyg compared with other sources of phototherapy (moderate certainty).
1 finding from 1 review
Hypothermia while receiving sunlight or conventional phototherapyk · infants with confirmed hyperbilirubinemia
Sunlight (with or without filters or amplification) showed no clear difference in hypothermia while receiving sunlight or conventional phototherapyk compared with other sources of phototherapy (moderate certainty).
1 finding from 1 review
MWD ‐ change from baseline · people with symptomatic peripheral arterial disease§
1 finding from 1 review
Change from baseline in 6MWT (metres) · people with symptomatic peripheral arterial disease§
1 finding from 1 review
PFWD (change in metres) (4–40 weeks' · people with symptomatic peripheral arterial disease§
1 finding from 1 review
ABI ‐ absolute value · people with symptomatic peripheral arterial disease§
1 finding from 1 review
All‐cause mortality · people with symptomatic peripheral arterial disease§
It is very uncertain whether supervised exercise therapy following vascular intervention changes mortality compared with vascular intervention alone (very low certainty).
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · people with symptomatic peripheral arterial disease§
1 finding from 1 review
Reintervention · people with symptomatic peripheral arterial disease§
It is very uncertain whether supervised exercise therapy following vascular intervention changes reintervention compared with vascular intervention alone (very low certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Surgical intervention · men with lower urinary tract symptoms secondary to benign prostatic obstruction
It is very uncertain whether combination therapy changes surgical intervention compared with alpha‐blockers (very low certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in adverse events compared with anticholinergics (moderate certainty).
1 finding from 1 review
AUR · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in AUR compared with anticholinergics (low certainty).
1 finding from 1 review
Surgical intervention – not reported · men with lower urinary tract symptoms secondary to benign prostatic obstruction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review